Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Contineum Therapeutics, Inc. (CTNM) is the issuer of Class A common stock for which Squadron Master Fund LP, Squadron Capital Management LLC, Matthew Sesterhenn and William Blank each report beneficial ownership of 1,700,000 shares, or approximately 5.1%. The entries describe the same fund holdings, not four separate blocks.
The reported position comprises 1,255,000 common shares and 445,000 shares underlying long call options held by Squadron Capital Management LLC that are currently exercisable. The percentage calculation uses 32,958,632 shares outstanding as of July 24, 2026, plus the 445,000 shares issuable upon option exercise. Squadron Capital Management LLC, Matthew Sesterhenn and William Blank expressly disclaim beneficial ownership of the reported securities.
Key Figures
Beneficial ownership:1,700,000 sharesCommon shares:1,255,000 sharesShares underlying long call options:445,000 shares+2 more
5 metrics
Beneficial ownership1,700,000 sharesReported for each of the four reporting persons as the same described holdings
Common shares1,255,000 sharesComponent of the reported beneficial ownership
Shares underlying long call options445,000 sharesCurrently exercisable options held by Squadron Capital Management LLC
Beneficial ownership percentageApproximately 5.1%Calculated using shares outstanding as of July 24, 2026, plus shares issuable upon option exercise
Shares outstanding32,958,632 sharesAs of July 24, 2026
Key Terms
beneficial ownership, long call options, currently exercisable, shared voting power
4 terms
beneficial ownershipregulatory
"Amount beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
long call optionsfinancial
"445,000 shares of Common Stock underlying long call options"
currently exercisablefinancial
"Options that are currently exercisable"
shared voting powerregulatory
"Shared voting power: 1,700,000 shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many CTNM shares are reported as beneficially owned?
The Schedule lists 1,700,000 shares, or approximately 5.1%, for each of the four reporting persons: Squadron Master Fund LP, Squadron Capital Management LLC, Matthew Sesterhenn and William Blank. These entries describe the same fund holdings.
What makes up the reported 1,700,000-share CTNM position?
The position comprises 1,255,000 common shares and 445,000 shares underlying long call options held by Squadron Capital Management LLC that are currently exercisable.
Who has voting and dispositive power over the reported CTNM shares?
Each reporting person is listed with shared voting power and shared dispositive power over 1,700,000 shares, and with zero sole voting power and zero sole dispositive power.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Contineum Therapeutics, Inc.
(Name of Issuer)
Class A Common Stock, par value $0.001 per share
(Title of Class of Securities)
21217B100
(CUSIP Number)
10/21/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
21217B100
1
Names of Reporting Persons
Squadron Master Fund LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,700,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,700,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,700,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
21217B100
1
Names of Reporting Persons
Squadron Capital Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,700,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,700,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,700,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
IA, HC
SCHEDULE 13G
CUSIP Number(s):
21217B100
1
Names of Reporting Persons
Matthew Sesterhenn
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,700,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,700,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,700,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
CUSIP Number(s):
21217B100
1
Names of Reporting Persons
William Blank
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,700,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,700,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,700,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Contineum Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CALIFORNIA, 92121.
Item 2.
(a)
Name of person filing:
Squadron Master Fund LP
Squadron Capital Management, LLC
Matthew Sesterhenn
William Blank
(b)
Address or principal business office or, if none, residence:
Squadron Master Fund LP
c/o Squadron Capital Management, LLC
1211 West 22nd Street, Suite 1008
Oak Brook, IL 60523
Squadron Capital Management, LLC
1211 West 22nd Street, Suite 1008
Oak Brook, IL 60523
Matthew Sesterhenn
c/o Squadron Capital Management, LLC
1211 West 22nd Street, Suite 1008
Oak Brook, IL 60523
William Blank
c/o Squadron Capital Management, LLC
1211 West 22nd Street, Suite 1008
Oak Brook, IL 60523
(c)
Citizenship:
Squadron Master Fund LP - Delaware
Squadron Capital Management, LLC - Delaware
Matthew Sesterhenn - United States
William Blank - United States
(d)
Title of class of securities:
Class A Common Stock, par value $0.001 per share
(e)
CUSIP Number(s):
21217B100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Squadron Capital Management, LLC is an investment adviser that is registered under the Investment Advisers Act of 1940. Squadron Capital Management, LLC, which serves as investment adviser to private funds, including but not limited to Squadron Master Fund LP (collectively, the "Funds"), may be deemed to be the beneficial owner of all shares of Common Stock held by the Funds. Mr. Sesterhenn and Mr. Blank, as Partners of Squadron Capital Management, LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owner of all shares of Common Stock held by the Funds. Pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended, Squadron Capital Management, LLC and Mr. Sesterhenn and Mr. Blank expressly disclaim beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission that Squadron Capital Management, LLC or Mr. Sesterhenn and Mr. Blank are the beneficial owner of any of the securities reported herein.
This amount comprises beneficial ownership of 1,700,000 shares of Common Stock which consists of (i) 1,255,000 shares of Common Stock and (ii) 445,000 shares of Common Stock underlying long call options held by Squadron Capital Management LLC that are currently exercisable (the "Options").
Squadron Master Fund LP - 1,700,000 shares
Squadron Capital Management, LLC - 1,700,000 shares
Matthew Sesterhenn - 1,700,000 shares
William Blank - 1,700,000 shares
(b)
Percent of class:
All such shares of Common Stock in the aggregate represent beneficial ownership of approximately 5.1% of the Common Stock based on (i) 32,958,632 shares of Common Stock outstanding, $0.001 par value per share, as of July 24, 2026, as reported by the Issuer on Form 10-Q filed with the Securities and Exchange Commission on July 30, 2026, plus (ii) 445,000 shares of Common Stock issuable upon exercise of the Options.
Squadron Master Fund LP - 5.1%
Squadron Capital Management, LLC - 5.1%
Matthew Sesterhenn - 5.1%
William Blank - 5.1%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Squadron Master Fund LP - 0
Squadron Capital Management, LLC - 0
Matthew Sesterhenn - 0
William Blank - 0
(ii) Shared power to vote or to direct the vote:
Squadron Master Fund LP - 1,700,000 shares
Squadron Capital Management, LLC - 1,700,000 shares
Matthew Sesterhenn - 1,700,000 shares
William Blank - 1,700,000 shares
(iii) Sole power to dispose or to direct the disposition of:
Squadron Master Fund LP - 0
Squadron Capital Management, LLC - 0
Matthew Sesterhenn - 0
William Blank - 0
(iv) Shared power to dispose or to direct the disposition of:
Squadron Master Fund LP - 1,700,000 shares
Squadron Capital Management, LLC - 1,700,000 shares
Matthew Sesterhenn - 1,700,000 shares
William Blank - 1,700,000 shares
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Notes above.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Squadron Master Fund LP
Signature:
/s/ Matthew Sesterhenn
Name/Title:
Partner, Squadron Partners LLC, its General Partner
